Fed. Circ. Affirms Hospira's Generic Adrenalin Loss To Par
The Federal Circuit on Monday affirmed a Delaware federal judge's ruling that Hospira's generic version of Par Pharmaceutical's epinephrine emergency allergy product Adrenalin infringes two valid patents covering the drug, leaving...To view the full article, register now.
Already a subscriber? Click here to view full article